With clinical information and expression profiles analysis, we found that Cathepsin B and PGE2 synthase-Cox-2 was significantly upregulated in recurrent glioma and HGG, compared to primary glioma and LGG, respectively. This evidence concerns the gene CTSB and central nervous system cancer.